Clinical Impact of Solifenacin on Generic and Symptom-Specific Quality of Life for Females with Overactive Bladder: Using the Overactive Bladder Symptom Score and Rand Medical Outcomes Study 36-Item Health Survey
LUTS: Lower Urinary Tract Symptoms, 05/17/2012Yano M et al.
Treatment of overactive bladder with solifenacin is associated with significant improvement in generic health–related quality of life (HRQoL) and disease–specific symptoms at 8 weeks after drug administration. Particularly for generic HRQoL as measured by the 36–Item Short Form Health Survey, solifenacin treatment effectively improves three SF–36 scores: physical function, vitality, and mental health.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.